MorphoSys AG: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs

MUNICH, GERMANY / ACCESSWIRE / March 2, 2023 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that the company will stop work and operations on its pre-clinical research programs to optimize its cost

Related Keywords

Germany ,Boston ,Massachusetts ,United States ,Munich ,Bayern ,Planegg ,Dennis Riedl ,Thomas Biegi ,Julia Neugebauer ,Eamonn Nolan ,Jean Paul Kress ,Morphosys Agview ,Exchange Commission ,Linkedin ,Twitter ,Chief Executive Officer ,Morphosy Annual Report ,Investor Relations ,Morphosys ,Stops ,Work ,Operations ,Linical ,Research ,Programs ,